Skip to main content
SpringerLink
Log in

Anti-inflammatories/azathioprine

Lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Country of occurrence, reporter country and primary source country not stated. Author's communication details not available.

Reference

  • Elmoursi A, et al. DEEP REMISSION WITH DOUBLE BIOLOGIC THERAPY: A SUCCESSFUL CASE OF COMBINATION USTEKINUMAB AND VEDOLIZUMAB FOR SEVERE REFRACTORY CROHN'S DISEASE. Inflammatory Bowel Diseases 26 (Suppl. 1): S72 abstr. P084, Jan 2020. Available from: URL: http://doi.org/10.1093/ibd/zaa010.182 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anti-inflammatories/azathioprine. Reactions Weekly 1969, 35 (2023). https://doi.org/10.1007/s40278-023-44501-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-44501-0

Search

Navigation